The NMC Specialty Hospital complex in Abu Dhabi. The company's joint administrators will begin legal action against former directors once restructuring is complete. Reuters
The NMC Specialty Hospital complex in Abu Dhabi. The company's joint administrators will begin legal action against former directors once restructuring is complete. Reuters
The NMC Specialty Hospital complex in Abu Dhabi. The company's joint administrators will begin legal action against former directors once restructuring is complete. Reuters
The NMC Specialty Hospital complex in Abu Dhabi. The company's joint administrators will begin legal action against former directors once restructuring is complete. Reuters

NMC Health's administrators to pursue claims once restructuring is complete


Michael Fahy
  • English
  • Arabic

The joint administrators of UAE healthcare group NMC Health have said they intend to begin legal action in a bid to recover part of the $4 billion that disappeared from the company.

Cases are expected to be filed once the group's restructuring through a Deeds of Company Arrangement, or Doca, is complete, Richard Fleming, joint administrator from Alvarez & Marsal, said.

A Doca refers to binding arrangement between a company and its creditors that details how the former's assets and operations are to be dealt with.

“Investigations on the cause and facilitation of the fraud, which was catalyst to the crisis that befell NMC in February 2020, is ongoing and progressing at pace," said Mr Fleming.

"Following the formal launch of the Doca, the joint administrators intend to start commencing legal actions.”

NMC Health was placed into administration in April last year. Problems at the UAE's biggest healthcare group first emerged in December 2019 after activist investor Muddy Waters issued a report claiming the company had under-reported its debts and inflated the value of its assets.

That triggered an investigation that uncovered more than $4.4bn of previously unreported debt. In total, $6.4bn worth of claims were filed with administrators from hundreds of creditors.

The proposed restructuring involves bringing the company's debt back down to a more manageable level of $2.25bn, with creditors receiving equity stakes in return for part of the $4bn-plus written off.

The deal had received "firm commitments" from most creditors, with companies representing 99 per cent of the allocated value in the restructured group acceding to proposals, administrators said last month.

However, it is understood that Dubai Islamic Bank, which is owed about $425m by NMC Health and is involved in ongoing legal disputes with NMC entities in onshore Dubai and Sharjah courts, has not agreed to the restructuring. DIB did not immediately respond to a request to comment.

In a progress report filed in May, NMC Health's administrators said they were continuing "to progress the investigation and formulation of claims" in a bid to pursue some of the missing money.

They issued letters before legal action to the group's former auditors, EY, and were in the process of issuing letters against "certain former directors of the company", they said, without naming them.

EY told The National at the time that it had "received correspondence from the administrators to NMC Health indicating an intention to pursue a claim", but declined to comment further.

The progress report said administrators had also received information requests from "various regulators and law enforcement agencies" including the UK's Serious Fraud Office and the Financial Conduct Authority, as well as the US Securities and Exchange Commission and the Department of Justice.

NMC Health's biggest lender, Abu Dhabi Commercial Bank, has already taken action in both UK and UAE courts to freeze the assets of former directors and of the group's founder and former chairman, BR Shetty.

Mr Shetty has denied any wrongdoing at the company, saying that bank accounts, cheques and bank guarantees were created in his name but without his knowledge, using forged signatures.


All%20The%20Light%20We%20Cannot%20See%20
%3Cp%3E%3Cstrong%3ECreator%3A%20%3C%2Fstrong%3ESteven%20Knight%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EStars%3A%C2%A0%3C%2Fstrong%3EMark%20Ruffalo%2C%20Hugh%20Laurie%2C%20Aria%20Mia%20Loberti%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ERating%3A%20%3C%2Fstrong%3E1%2F5%C2%A0%3C%2Fp%3E%0A
How%20to%20avoid%20getting%20scammed
%3Cul%3E%0A%3Cli%3ENever%20click%20on%20links%20provided%20via%20app%20or%20SMS%2C%20even%20if%20they%20seem%20to%20come%20from%20authorised%20senders%20at%20first%20glance%3C%2Fli%3E%0A%3Cli%3EAlways%20double-check%20the%20authenticity%20of%20websites%3C%2Fli%3E%0A%3Cli%3EEnable%20Two-Factor%20Authentication%20(2FA)%20for%20all%20your%20working%20and%20personal%20services%3C%2Fli%3E%0A%3Cli%3EOnly%20use%20official%20links%20published%20by%20the%20respective%20entity%3C%2Fli%3E%0A%3Cli%3EDouble-check%20the%20web%20addresses%20to%20reduce%20exposure%20to%20fake%20sites%20created%20with%20domain%20names%20containing%20spelling%20errors%3C%2Fli%3E%0A%3C%2Ful%3E%0A
Sinopharm vaccine explained

The Sinopharm vaccine was created using techniques that have been around for decades. 

“This is an inactivated vaccine. Simply what it means is that the virus is taken, cultured and inactivated," said Dr Nawal Al Kaabi, chair of the UAE's National Covid-19 Clinical Management Committee.

"What is left is a skeleton of the virus so it looks like a virus, but it is not live."

This is then injected into the body.

"The body will recognise it and form antibodies but because it is inactive, we will need more than one dose. The body will not develop immunity with one dose," she said.

"You have to be exposed more than one time to what we call the antigen."

The vaccine should offer protection for at least months, but no one knows how long beyond that.

Dr Al Kaabi said early vaccine volunteers in China were given shots last spring and still have antibodies today.

“Since it is inactivated, it will not last forever," she said.

Company info

Company name: Entrupy 

Co-founders: Vidyuth Srinivasan, co-founder/chief executive, Ashlesh Sharma, co-founder/chief technology officer, Lakshmi Subramanian, co-founder/chief scientist

Based: New York, New York

Sector/About: Entrupy is a hardware-enabled SaaS company whose mission is to protect businesses, borders and consumers from transactions involving counterfeit goods.  

Initial investment/Investors: Entrupy secured a $2.6m Series A funding round in 2017. The round was led by Tokyo-based Digital Garage and Daiwa Securities Group's jointly established venture arm, DG Lab Fund I Investment Limited Partnership, along with Zach Coelius. 

Total customers: Entrupy’s customers include hundreds of secondary resellers, marketplaces and other retail organisations around the world. They are also testing with shipping companies as well as customs agencies to stop fake items from reaching the market in the first place. 

The Sand Castle

Director: Matty Brown

Stars: Nadine Labaki, Ziad Bakri, Zain Al Rafeea, Riman Al Rafeea

Rating: 2.5/5

While you're here
Updated: July 18, 2021, 3:57 PM